Professor Tim Coats’ research focuses on emergency and trauma care and Accident and Emergency services. His expertise is helping to address some of the many challenges the COVID-19 pandemic presents in delivering healthcare in hospitals.
Working in personal protective equipment (PPE) brings a number of difficulties, including a decreased ability for clinical staff to talk to each other, to patients or to relatives. Critical conversations are often difficult, but the use of respirator masks makes them nearly impossible, particularly for patients with hearing loss or communication difficulties. Professor Coats is working with industry partners to design and build a new communications system that overcomes the problems caused by masks and respirators.
Professor Coats is also chairing a study into the early identification of COVID-19 in ambulances and emergency care, which aims to better predict which patients require admitting to hospital.
Reed MJ, Grubb NR, Lang CC, et al. Multi-centre Randomised Controlled Trial of a Smartphone-based Event Recorder Alongside Standard Care Versus Standard Care for Patients Presenting to the Emergency Department with Palpitations and Pre-syncope: The IPED (Investigation of Palpitations in the ED) study. EClinicalMedicine 2019;8:37-46. doi: https://doi.org/10.1016/j.eclinm.2019.02.005
Desborough M, Salman R-S, Stanworth S, et al. Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): rationale and design of a phase II double blind randomised controlled trial. 2019
Davies F, Coats TJ. ‘Stealth trauma’in the young and the old: the next challenge for major trauma networks? Emergency medicine journal 2019:emermed-2019-208694.
Coats TJ, Fragoso-Iñiguez M, Roberts I. Implementation of tranexamic acid for bleeding trauma patients: a longitudinal and cross-sectional study. Emerg Med J 2019;36(2):78-81.
Brenner A, Afolabi A, Ahmad SM, et al. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial. Trials 2019;20(1):467.
Clinical evaluation of a prototype 'brain tv' (tissue velocimetry) ultrasound system for emergency assessment of suspected acquired brain injury. Journal of Cerebral Blood Flow and Metabolism; 2019. Sage Publications Inc 2455 Teller Rd, Thousand Oaks, Ca 91320 USA.
Implementation of tranexamic acid for bleeding trauma patients: a longitudinal and cross-sectional study. Coats TJ, Fragoso-Iñiguez M, Roberts I. Emerg Med J. 2019 Feb;36(2):78-81. doi: 10.1136/emermed-2018-207693. Epub 2018 Dec 8.
Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Harvey SE, Bell D, Bion JF, Coats TJ, Singer M, Young JD, and Rowan KM, for the ProMISe Trial Investigators. (2015). Trial of early, goal-directed resuscitation for septic shock. N Engl J Med, 372(14), 1301-1311.
Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MP, Ahern A, Griggs K, Scott R, Hinds C, Rowan K; OPTIMISE Study Group. Inc Coats TJ. (2014) Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. June 4;311(21):2181-90
Goodacre S, Cohen J, Bradburn M, Gray A, Benger J, Coats T; 3Mg Research Team. Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial.Lancet Respir Med. 2013 Jun;1(4):293-300
Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt BJ, Lecky F, Brohi K, Willett K; CRASH-2 Collaborators. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ. 2012 Sep 11;345:e5839